» Authors » Yannick Le Guen

Yannick Le Guen

Explore the profile of Yannick Le Guen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 38
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pierre C, Le Guen Y, Giordanengo C, Goter T, Lena H, Niel C, et al.
Transl Lung Cancer Res . 2024 Sep; 13(8):1807-1815. PMID: 39263023
Background: Pembrolizumab 400 mg every six weeks (Q6W) and nivolumab 480 mg every four weeks (Q4W) are used since 2020 and the coronavirus disease 2019 (COVID-19) pandemic. This recommendation relied...
2.
Pierre C, Goter T, Lena H, Le Guen Y, Ricordel C
J Thorac Oncol . 2023 Jan; 18(2):e14-e16. PMID: 36682842
No abstract available.
3.
Kamga A, Rochefort-Morel C, Le Guen Y, Ouksel H, Pipet A, Leroyer C
Respir Med Res . 2022 Jul; 82:100916. PMID: 35901579
Asthma occurrence is often associated with cigarette smoking. Surprisingly, active smokers are excluded from most clinical studies. Prevalence of asthma associated with smoking appears to be similar to asthma in...
4.
Guilleminault L, Ouksel H, Belleguic C, Le Guen Y, Germaud P, Desfleurs E, et al.
Eur Respir Rev . 2017 Jan; 26(143). PMID: 28049124
The concept of asthma has changed substantially in recent years. Asthma is now recognised as a heterogeneous entity that is complex to treat. The subdivision of asthma, provided by "cluster"...
5.
Le Guen Y, Gagnadoux F, Hureaux J, Jeanfaivre T, Meslier N, Racineux J, et al.
Lung Cancer . 2007 Jul; 58(1):139-43. PMID: 17614157
Background: Clinical experience suggests that lung cancer (LC) is associated with sleep disturbances that may contribute to impaired daytime functioning and quality of life. Using questionnaires and home actigraphic recordings,...
6.
Ouksel H, Le Guen Y, Racineux J
Rev Prat . 2004 Oct; 54(13):1425-31. PMID: 15497796
The term chronic obstructive pulmonary disease (COPD) is mainly characterised by an irreversible obstructive airway obstruction, that in most cases, is secondary to tobacco exposure. Management of the disease includes...
7.
Le Guen Y, Cesne A
Bull Cancer . 2004 Jun; 91(3):263-70. PMID: 15171051
Docetaxel (Taxotere) is a taxoid used in various tumoral diseases. Its role in metastatic or locally advanced non small cell lung cancer treatment is undeniable. In pretreated patients with metastatic...
8.
Le Guen Y, Sabatier L, Le Chevalier T, Soria J
Bull Cancer . 2004 Jan; 90(12):1055-61. PMID: 14715425
Molecular targeted therapies offer great hope in lung cancer because they are supposed to act upon biologic abnormalities specific to cancer cells. In the present review, we will describe the...
9.
Le Guen Y, Soria J, Ruffie P
Bull Cancer . 2003 Jun; 90(3):199-201. PMID: 12801821
No abstract available.